Trademark

GLP-1 Companion Trademark Information

Number:
2646783
Words:
GLP-1 Companion
Kind:
Word
Status group:
PENDING
Status code:
Published
Status detail:
Under examination
Priority date:
23 Apr 2026
Lodgement date:
23 Apr 2026
First report date:
19 Jun 2026
Acceptance due date:
19 Sep 2027
Filing date:
23 Apr 2026
Indexing constituents:
GLP1, 1, NUM, GLP, COMPANION, =GLP, LTR
Class:
5
Mark categories:
Trademark
Last status check:
2026-07-11 13:15:24
Goods and services:
1) Class: 5
Description: pharmaceuticals, pills being pharmaceuticals, pharmaceutical drugs, pharmaceutical substances, tablets being pharmaceuticals, pharmaceutical products and preparations, homeopathic pharmaceuticals, pharmaceuticals containing active chemical ingredients, pharmaceutical and medical preparations, pharmaceutical substances and preparations, pharmaceuticals, medical and veterinary preparations, pharmaceuticals containing active chemical agents, pills [pharmaceuticals], pharmaceutical preparations and substances, antibacterial pharmaceuticals, pastilles being pharmaceuticals, pharmaceutical products for use by humans, pharmaceuticals for the treatment of infectious diseases, chemical products for pharmaceutical use, chemical products for pharmaceutical purposes, pharmaceutical preparations, anti-diabetic pharmaceuticals, pharmaceutical preparations and substances with analgesic properties, lozenges being pharmaceuticals, pharmaceutical products, medical and veterinary preparations, ethanol for pharmaceutical purposes, pharmaceuticals for the prevention and treatment of cancer, pharmaceutical pills, cardiovascular pharmaceuticals, pharmaceuticals for the treatment of bone diseases, tablets [pharmaceuticals], pharmaceutical tablets, pharmaceuticals for the treatment of cancer, pharmaceutical preparations for human purposes, pharmaceutical antiallergic preparations and substances, pharmaceuticals for the treatment of viral diseases, dietary supplements for pharmaceutical use, pastilles [pharmaceuticals], pharmaceutical preparations for human use, chemical preparations for pharmaceutical use, antidiabetic pharmaceuticals, pharmaceuticals containing lactic acid bacteria, elixirs [pharmaceutical preparations], dietary supplements for pharmaceutical purposes, chemical preparations for pharmaceutical purposes, propolis for pharmaceutical purposes, pharmaceutical preparations for health care, pharmaceuticals for ophthalmological use, pharmaceutical preparations for the treatment of various diseases, pharmaceutical preparations containing hormones for human beings, medicine, alcohol for pharmaceutical purposes, medicines, lozenges [pharmaceuticals], pharmaceutical preparations and substances with antipyretic properties, pharmaceutical preparations and substances with anti-inflammatory properties, clay for pharmaceutical use, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, pharmaceutical preparations containing hormones for humans, pharmaceutical anti-allergic preparations and substances, acids for pharmaceutical purposes, chemical products for therapeutic use, topical pharmaceutical preparations, drugs for medical purposes, drugs for medical use, clay for pharmaceutical purposes, peptones for pharmaceutical purposes, pills for pharmaceutical purposes, chemical products for therapeutical use, pharmaceutical pastilles, pharmaceutical preparations containing active chemical ingredients, gelatin capsules for pharmaceuticals, pharmaceutical cough preparations, stimulants for pharmaceutical purposes, iodine for pharmaceutical purposes, pharmaceutical preparations for diagnostic purposes, pharmaceutical preparations being hormone preparations for human use, antibacterial pharmaceutical preparations, aldehydes for pharmaceutical purposes, pharmaceutical preparations containing active chemical agents, drug delivery agents that facilitate the delivery of pharmaceutical preparations, pharmaceutical cold preparations, chemical products for therapeutical purposes, charcoal for pharmaceutical purposes, pharmaceutical products for the prevention of diseases of the endocrine system, iodides for pharmaceutical purposes, human plasma protein being pharmaceutical preparations, chemicals for medical use, pharmaceutical products for the treatment of disorders of the endocrine system, therapeutic drugs and agents, ethers for pharmaceutical purposes, diagnostic agents for pharmaceutical use, chemical products for medical use, pharmaceutical preparations and substances for use in oncology, pharmaceutical products for the treatment of diseases caused by bacteria, pharmaceutical preparations for the prevention and treatment of eye diseases and conditions, pharmaceutical preparations and substances for the treatment of cancer, medicinal substances and preparations, starch and starch products for pharmaceutical purposes, pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, menthol for pharmaceutical purposes, chemical products for therapeutic purposes, dermatological pharmaceutical substances, human coagulation factors being pharmaceutical preparations, ocular pharmaceuticals, pharmaceutical agents affecting metabolism, pharmaceutical preparations and substances for the prevention of cancer, pharmaceutical and biological preparations for diagnostic purposes, pharmaceutical preparations and substances for the treatment of diabetes, cardiovascular pharmaceutical preparations, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations and biological preparations for diagnostic purposes, pharmaceutical preparations for the treatment of hormonal disorders, pharmaceutical products for use in hematology, potassium preparations for pharmaceutical purposes, pharmaceutical products for the prevention of disorders of the endocrine system, chemicals for medical purposes, chemico-pharmaceutical products, pharmaceutical products for the prevention of diabetes, pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders, pharmaceutical preparations for skincare, pharmaceutical skin lotions, pharmaceutical preparations for skin care, antiepileptic pharmaceutical preparations, medicinal preparations and substances, pharmaceutical products for the prevention of diseases of the nervous system, pharmaceutical preparations for the prevention and treatment of eye diseases, pharmaceutical preparations for treating cardiovascular diseases, human coagulation factors [pharmaceutical preparations], pharmaceutical preparations for use in immunotherapies, pharmaceutical lozenges, medicinal healthcare preparations, pharmaceutical preparations and substances for the prevention of cardiovascular diseases and disorders, pharmaceutical solutions used in dialysis, pharmaceutical preparations for the treatment of rare diseases, pharmaceutical preparations for topical use, flour for pharmaceutical purposes, capsules, empty, for pharmaceuticals, biochemical drugs, pharmaceutical preparations containing amino acids, mineral salts for pharmaceutical use, pharmaceutical and veterinary preparations for medical purposes, pharmaceutical preparations for the prevention and treatment of hypertension, phosphates for pharmaceutical purposes, dermatological pharmaceutical products, diagnostic agents for pharmaceutical purposes, pharmaceutical products for the prevention of diseases of the musculoskeletal system, synthetic peptides for pharmaceutical purposes, pharmaceutical compositions containing stem cells, pharmaceutical preparations and substances for the prevention of diabetes, pharmaceutical preparations for the treatment of cardiovascular diseases, pharmaceutical preparations for the prevention and treatment of diabetes, pharmaceutical preparations for the treatment of hypertension, aluminium acetate for pharmaceutical purposes, lactose for pharmaceutical purposes, pharmaceutical products for the prevention of diseases caused by bacteria, pharmaceutical preparations for the treatment of bone diseases, chemical products for medical purposes, pharmaceutical preparations for the treatment of chemical imbalances, pharmaceutical preparations and substances for the prevention of metabolic diseases and disorders, liquorice for pharmaceutical purposes, medicines for human purposes, pharmaceutical products for the prevention of disorders of the cardiovascular system, aluminum acetate for pharmaceutical purposes, pharmaceutical preparations and compositions for the treatment and prevention of cancer, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the endocrine system, human plasma protein [pharmaceutical preparations], pharmaceutical preparations for the treatment of diabetes, mineral salts for pharmaceutical purposes, pharmaceutical preparations for the prevention and treatment of bone diseases, pharmaceuticals for treating the symptoms of radiation sickness, empty capsules for pharmaceuticals, magnesium salts for pharmaceutical use, parapharmaceutical preparations, pharmaceutical preparations for the prevention and treatment of skin diseases, pharmaceutical preparations for activating cellular function, pharmaceutical preparations for the prevention and treatment of cancer, psychedelic compounds for pharmaceutical use, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations and substances for use in the field of anesthesia, gelatine capsules for pharmaceuticals, biochemical drug, pharmaceutical preparations for the treatment of Parkinson's disease, yeast for pharmaceutical use, pharmaceutical preparations for treating hypertension, psychotropic drugs for pharmaceutical use, crude drugs, pharmaceutical preparations for dental purposes, guaiacol for pharmaceutical purposes, pharmaceutical products for the prevention of disorders of the musculoskeletal system, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for the treatment of cardiovascular disease, pharmaceutical agents affecting peripheral nervous system, pharmaceutical preparations for treating chemical imbalances, yeast for pharmaceutical purposes, psychedelic compounds for pharmaceutical purposes, capsules sold empty for pharmaceuticals, medicated foodstuff additives for pharmaceutical use, pharmaceutical preparations for the prevention and treatment of skin disorders, esters for pharmaceutical purposes, pharmaceutical products for use in organ transplantation, pharmaceuticals for the treatment of erectile dysfunction, pharmaceutical preparations for cancer imaging, diagnosis and monitoring, psychotropic drugs for pharmaceutical purposes, food esters for pharmaceutical use, pharmaceutical products for the treatment of disorders caused by bacteria, chemical preparations for therapeutical use, psychotropic compounds for pharmaceutical use, pharmaceutical preparations for dental use, magnesium salts for pharmaceutical purposes, pharmaceutical preparations and substances for the treatment of damaged skin and tissue, pharmaceutical preparations for the treatment of the skin, pharmaceuticals for treating respiratory diseases, pharmaceutical preparations for the prevention of diabetes, pharmaceutical preparations for the preservation and storage of human organs, syrups for pharmaceutical purposes, phenol for pharmaceutical purposes, pharmaceutical preparations for the treatment of cancer, human albumin [pharmaceutical preparations], diagnostic preparations for medical and pharmaceutical use, adhesive patches incorporating pharmaceutical products, biotechnological preparations for medical use, pharmaceutical preparations and substances for use in the field of anaesthesia, intravenous fluids used for the delivery of pharmaceutical preparations, decoctions for pharmaceutical purposes, chemical preparations for therapeutic use, pharmaceutical preparations containing stem cells, caustics for pharmaceutical purposes, pharmaceutical preparations for the prevention of diseases of the endocrine system, oils for pharmaceutical purposes, pharmaceutical preparations for the prevention and treatment of cancer and tumors, adhesive patches containing pharmaceutical products, crude medicines, psychedelic drugs for pharmaceutical use, pharmaceutical preparations for the prevention of tumors, catechu for pharmaceutical purposes, ethyl alcohol for pharmaceutical purposes, pharmaceutical products for the prevention of disorders of the metabolic system, psychotropic compounds for pharmaceutical purposes, medicinal preparations, pharmaceutical products for the treatment of diseases of the genitourinary system, thymol for pharmaceutical purposes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the metabolic system, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the musculoskeletal system, radiopharmaceutical preparations, pharmaceutical antitussive-cold preparations, psychedelic drugs for pharmaceutical purposes, pharmaceutical preparations for the peripheral nervous system, malt for pharmaceutical purposes, cachets for pharmaceutical purposes, pharmaceutical products for the prevention of diseases of the genitourinary system, bismuth preparations for pharmaceutical purposes, pharmaceutical preparations for the treatment of disorders of the endocrine system, pharmaceutical preparations for use in oncology, chemical preparations for therapeutical purposes, biochemical medicines, pharmaceutical preparations for the treatment of hypercholesterolemia, psychedelics for pharmaceutical use, chemical preparations for medical use, medicated foodstuff additives for pharmaceutical purposes, capsules made of dendrimer-based polymers, for pharmaceuticals, pharmaceutical products for the prevention of autoimmune diseases, pharmaceutical preparations for treating metabolic disorders, pharmaceutical preparations containing caffeine, pharmaceutical products for the treatment of disorders of the genitourinary system, pharmaceutical preparations and substances for use in gynecology, pharmaceutical preparations for peripheral nervous system, pharmaceutical preparations for the prevention of disorders of the endocrine system, magnesia for pharmaceutical purposes, medicinal health care preparations, milk sugar for pharmaceutical purposes, plant extracts for pharmaceutical use, pharmaceutical preparations for imaging, diagnosing and monitoring of cancer, pharmaceutical preparations for the treatment of viral diseases
History and publication details:
1) Date: 2026-06-19
Display name: Adverse Report (Examination) correspondence sent
2) Date: 2026-06-19
Display name: IP Right has been Examined
3) Date: 2026-06-19
Display name: Owner name details updated
Description: Owner: NIRO Brands Pty Ltd
Previous details: Owner: NIRO Brands
New details: Owner: NIRO Brands Pty Ltd
4) Date: 2026-04-28
Display name: Awaiting examination
5) Date: 2026-04-28
Display name: Word and image indexing completed
6) Date: 2026-04-23
Display name: IP Right Filed correspondence sent
7) Date: 2026-04-23
Display name: IP Right Filed Published
8) Date: 2026-04-23
Display name: Status change to Published
9) Date: 2026-04-23
Display name: Status change to Filed
10) Date: 2026-04-23
Display name: Minimum Filing Requirements Considered
11) Date: 2026-04-23
Display name: Status change to Received
12) Date: 2026-04-23
Display name: Trade mark representation updated
13) Date: 2026-04-23
Display name: Application Received

Owner Information
Owner Acn:
695293433

Owner structured address:
45 Maida St, Lilyfield, NSW, AUSTRALIA, Postal Code: 2040

Owner is private:
0

Service Information
Address Acn:
695293433

Address name:

Address structured address:
45 Maida St, Lilyfield, NSW, AUSTRALIA, Postal Code: 2040

Address is private:
0
Scroll to Top